Frontera is a leader in life-changing therapeutics that reach patients around the globe. Because of our innovative development platform, our treatments are accessible to patients regardless of geography or livelihood. Frontera's rich product pipeline covers multiple therapeutic areas and is in various stages of development.
Location: United States, Massachusetts, Bedford
Employees: 51-200
Total raised: $160M
Investors 2
| Date | Name | Website |
| - | Terra Magn... | terramagnu... |
| - | OrbiMed | orbimed.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.07.2022 | Series B | $160M | - |
Mentions in press and media 3
| Date | Title | Description |
| 20.07.2022 | Frontera Therapeutics Closes $160M Series B Financing | Frontera Therapeutics, a Bedford, MA and Suzhou, China-based clinical-stage biotechnology company that seeks to develop novel and best-in-class gene therapy medicines to improve the lives of patients across multiple disease areas, closed a ... |
| 19.07.2022 | Frontera Therapeutics Completes $160 Million Series B Financing to Fund Clinical Development and Manufacturing Capabilities | - |
| 19.07.2022 | Frontera Therapeutics Completes $160 Million Series B Financing to Fund Clinical Development and Manufacturing Capabilities | FDA clears Investigational New Drug (IND) application for lead gene therapy product candidate, FT-001, for the treatment of a rare inherited eye disease leading to severe visual impairment that may result in blindness Investors in the $160 ... |